Venture Capital Investors

Evogene

Evogene is a VC investing group that helps tech entrepreneurs.

Venture Investor Overview

Contact Information

Background Information

Overview

Evogene (NASDAQ:EVGN, TASE: EVGN.TA) is a leading computational biology company focused on revolutionizing product discovery and development in multiple life-science based industries, including human health and agriculture, through the use of our broadly applicable Computational Predictive Biology (CPB) platform. The CPB platform, incorporating a deep understanding of biology leveraged through the power of Big Data and Artificial Intelligence, has been designed to computationally discover and uniquely guide the development of life-science products based on microbes, small molecules and genetic elements.

Profile

Social Media

Company News

Facebook

YouTube

Last Transaction

4/27/2023

Transaction History

Our records indicate that Evogene invested in the VC transactions listed below. Dollar amounts are for the entire raise, which may include other investors.

Investor Contacts

Title

Name

Email & Social

Chief Financial Officer

Yaron Eldad

        

Chief Executive Officer

Ofer Haviv

        

Chief Technology Officer

Mark Kapel

        

Vice President

Sassi Masliah

        

Funds

No fund closings have been recorded for this company.

Portfolio Companies

Evogene has invested in only one tech company, according to our database records. If we are missing a portfolio company, please let us know.

Browse more venture capital investors:

EVO Venture Partners | Evok Innovations

Share this article

About Our Venture Capital Investors Database

The venture capital investor data above is provided by VentureDeal.com, a market leader in private equity transaction data.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary